Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,653 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
Oil prices hovered near $86 per barrel early today, with Brent as the benchmark. Markets weigh demand signals, supply...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
The BEA reports the U.S. economy expanded at a 1.4% annualized rate in Q4, far below economists' 3% projection. The s...
The record between corporate profits and worker pay has widened to a postwar high, signaling a troubling drift in the...
Click n’ Close appoints Rachel Fatino to head its correspondent operations, aiming to expand partnerships and tighten...
A 2.8% cost-of-living bump boosts checks in January, but higher Medicare costs and a government scheduling overhaul m...
Zscaler posted a strong quarter, beating revenue and EPS estimates while signaling durable ARR growth. Here are the n...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
Apple unveiled a refreshed iPhone and iPad Air lineup with bigger storage, underscoring a broader AI push. The move a...